Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
NOVT vs ARAI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NOVT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)
NOVT Overall Winner
6-Pillar Tally: NOVT 4 – 2 ARAI
Matrix Metrics: NOVT 8 – 2 ARAI
As of Nov 20, 2026, Novanta Inc. (NOVT) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). NOVT carries a Unified Composite Score of 40.2/100 (SELL) at $101.99 (23.9x Forward P/E, 11.8% operating margin), whereas ARAI carries 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin).
- Growth vs. Quality Trade-Off: NOVT earns the overall head-to-head edge with a stronger Unified Composite Score (40.2/100 SELL vs. ARAI 34.4/100 SELL) and 2.02β · 83% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
- Defensive Composite Rating Caution: Although NOVT compares more favorably head-to-head, both NOVT (40.2/100 SELL) and ARAI (34.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: NOVT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.8); meanwhile ARAI trades in a Markup technical trend (SURGE options phase, RSI 58.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About NOVT vs ARAI
NOVT
Head-to-Head Winner
Novanta Inc. Common Stock
$101.99
-11.22% 1D
Market Cap
$4.3B
TTM Revenue
$1.09B
Forward P/E
23.9x
Beta / 30D Vol
2.02β · 83% Vol
Unified Composite Score
40.2
SELL
Tech 25.0
Fund 46.0
Flow 58.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
ARAI
Arrive AI Inc. Common Stock
$1.21
-21.94% 1D
Market Cap
$2.2M
TTM Revenue
$84,400
Forward P/E
N/M
Beta / 30D Vol
-4.44β · 11485% Vol
Unified Composite Score
34.4
SELL
Tech 50.0
Fund 32.0
Flow 50.0
Mom 58.9
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (NOVT 4 – 2 ARAI)
1. Valuation Multiples
NOVT
Forward P/E
23.9x
N/M
Trailing P/E
87.0x
N/M
PEG Ratio
2.11x
N/M
EV / Revenue
4.7x
55.5x
2. Growth & Scale
ARAI
Revenue Growth (YoY)
+23.1%
+432.9%
Earnings Growth (YoY)
-84.0%
+0.0%
TTM Revenue (USD)
$1.09B
$84,400
Market Cap
$4.3B
$2.2M
3. Profitability & Quality
NOVT
Gross Margin
44.5%
100.0%
Operating Margin
11.8%
-18105.8%
Net Profit Margin
4.9%
0.0%
Return on Equity (ROE)
4.4%
-840.7%
4. Balance Sheet & Cash Flow
NOVT
Cash Generation (TTM)
$140M
-$15M EBITDA
Cash Flow Margin
12.9%
N/A
Net Cash / Leverage
$744M Net Debt (0.55x D/E)
$2.5M Net Debt (1.15x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ARAI
Options Structure Phase
BREAKDOWN
SURGE
Current IV / %ile
59.8% (13th %ile)
N/A (N/A)
Put/Call OI Skew
4.10x (Put-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
ACCUMULATION · Markup
6. R&D & Supply-Chain Moat
NOVT
OpEx & R&D Intensity
32.7% of Rev ($355M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Scientific & Technical Instruments Operator
Scientific & Technical Instruments Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: NOVT (8) vs ARAI (2)| Institutional Metric | NOVT | ARAI | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $4.3B | $2.2M | NOVT | |
| Trailing P/E Ratio | 87.0x | N/M | NOVT | |
| Forward P/E Ratio | 23.9x | N/M | NOVT | |
| Revenue Growth (YoY) | +23.1% | +432.9% | ARAI | |
| Operating Margin (TTM) | 11.8% | -18105.8% | NOVT | |
| Net Profit Margin | 4.9% | 0.0% | NOVT | |
| Return on Equity (ROE) | 4.4% | -840.7% | NOVT | |
| 52-Week Range Position | 5% ($98–$176) | 28% ($0–$4) | ARAI | |
| Beta / 30D Volatility | 2.02β · 83% Vol | -4.44β · 11485% Vol | NOVT | |
| Unified Institutional Score | 40.2 / 100 (SELL) | 34.4 / 100 (SELL) | NOVT | |
| Trailing 12M Revenue (USD) | $1.09B | $84,400 | Scale | |
| Gross Profit Margin (TTM) | 44.5% | 100.0% | Quality | |
| PEG Ratio & EV / Revenue | 2.11x PEG · 4.7x EV/Rev | N/M PEG · 55.5x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $140M ($744M Net Debt (0.55x D/E)) | -$15M EBITDA ($2.5M Net Debt (1.15x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ARAI +879.63 pp
3M Horizon
ARAI +450.46 pp
6M Horizon
ARAI +124.85 pp
1Y Horizon
NOVT +68.18 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NOVT Revenue | ARAI Revenue | NOVT Op. Margin | ARAI Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $610M | N/A | 11.6% | N/A | NOVT |
| FY2019 | $630M | N/A | 8.8% | N/A | NOVT |
| FY2020 | $590M | N/A | 9.5% | N/A | NOVT |
| FY2021 | $710M | N/A | 9.1% | N/A | NOVT |
| FY2022 | $860M | N/A | 12.0% | N/A | NOVT |
| FY2023 | $880M | N/A | 12.5% | N/A | NOVT |
| FY2024 | $950M | N/A | 11.6% | N/A | NOVT |
| FY2025 | $980M | $0M | 9.6% | -11325.7% | NOVT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
NOVT
BREAKDOWN
Current IV
59.8%
IV Percentile
13th %ile
Put/Call OI Skew
4.10x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact NOVT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ARAI
SURGE
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Exact ARAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
NOVT Moat Profile
Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
OpEx & R&D Reinvestment
32.7% of Rev ($355M)
90D Engineering Disclosures
0 Published
Analog Devices
Texas Instruments
STMicroelectronics
Infineon Technologies
ARAI Moat Profile
Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ NOVT vs ARAI Key Questions & Quantitative Answers
As of Nov 20, 2026, Novanta Inc. (NOVT) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). NOVT carries a Unified Composite Score of 40.2/100 (SELL) at $101.99 (23.9x Forward P/E, 11.8% operating margin), whereas ARAI carries 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin). Growth vs. Quality Trade-Off: NOVT earns the overall head-to-head edge with a stronger Unified Composite Score (40.2/100 SELL vs. ARAI 34.4/100 SELL) and 2.02β · 83% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although NOVT compares more favorably head-to-head, both NOVT (40.2/100 SELL) and ARAI (34.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: NOVT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.8); meanwhile ARAI trades in a Markup technical trend (SURGE options phase, RSI 58.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ARAI leads the Growth & Scale pillar: NOVT posts +23.1% YoY revenue growth and -84.0% YoY earnings growth on $1.09B TTM revenue (44.5% gross margin, 11.8% operating margin), compared with ARAI at +432.9% YoY revenue growth and +0.0% YoY earnings growth on $84,400 TTM revenue (100.0% gross margin, -18105.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), NOVT cumulative revenue shifted +60.7% while ARAI shifted N/A. In operating R&D and SG&A reinvestment, NOVT deploys 32.7% of Rev ($355M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ARAI.
NOVT screens cheaper on headline valuation multiples. NOVT trades at 23.9x Forward P/E, 87.0x Trailing P/E, 2.11x PEG, and 4.7x EV/Revenue (12.9% FCF margin), whereas ARAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 55.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NOVT (4.4% ROE) versus ARAI (-840.7% ROE) capital efficiency.
In options market volatility and institutional positioning, NOVT carries 59.8% implied volatility (13th %ile, Compressed (<25th %ile)), a 4.10x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.02β · 83% Vol realized risk). By comparison, ARAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (-4.44β · 11485% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ARAI vs NOVT · Reverse Pair
NOVT vs VPG
· Sector Peer
NOVT vs RRX
· Sector Peer
NOVT vs SPSC
· Sector Peer
ARAI vs BNAI
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma